Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia von Gibson, Amber, Nunez, Cesar, Robusto, Lindsay, Kammerer, Brianna, Garcia, Miriam, Roth, Michael, Sheth, Rachna, Tewari, Priti, Hittle, Aline, Toepfer, Laurie, Torres, Romeo, Short, Nicholas J, Jabbour, Elias, Jain, Nitin, Cuglievan, Branko, McCall, David

Volltext

Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in A... von Issa, Ghayas C., Cuglievan, Branko, DiNardo, Courtney D., Short, Nicholas J., McCall, David, Gibson, Amber, Nunez, Cesar, Garcia, Miriam B., Roth, Michael, Bidikian, Aram, Pike, Allison, Tan, Sheila, Kammerer, Brianna, Yilmaz, Musa, Kadia, Tapan M., Pemmaraju, Naveen, Ohanian, Maro, Daver, Naval, Jabbour, Elias, Borthakur, Gautam, Ravandi, Farhad, Garcia-Manero, Guillermo, Andreeff, Michael, Kantarjian, Hagop M.

Volltext